Skip to main content
Premium Trial:

Request an Annual Quote

MultiProbe II Nucleic Acid Normalization, rat array, Rosetta Luminator, OmniGrid, HiLight Array Detection System, Qiagen.

Premium

PerkinElmer Life Sciences has introduced its MultiProbe II Nucleic Acid Normalization workstation for automated, high-throughput normalization of nucleic acid samples. The Boston-based company co-markets the system with Molecular Devices.

MWG Biotech of High Point, NC and Ebersberg, Germany has launched a rat array containing gene-specific probes representing 10,000 unique rat genes. In addition to the 5,535 genes from public databases, it presents another 4,105 genes from an in-house EST sequencing project.

Rosetta Biosoftware of Kirkland, Wash., and Agilent Technologies of Palo Alto, Calif., have introduced Rosetta Luminator, a client-server bioinformatics system for storing and analyzing microarray data. The system will be distributed exclusively by Agilent. Version 1.0 of Rosetta Luminator includes a subset of the features from the Rosetta Resolver system and can be upgraded to this system.

San Carlos, Calif.-based GeneMachines has launched its OmniGrid slides and reagents for microarray experiments, available with aldehyde, epoxy, or amine surfaces.

Genicon Sciences of San Diego has launched One-Color Microarray Toolkit, a signal generation and detection system for microarrays based on the company''s proprietary resonance light scattering (RLS) non-fluorescent technology. The kit is part of the HiLight Array Detection System, available through distribution partner Qiagen. RLS technology is based on the physical properties of nano-sized metallic particles which scatter light when illuminated.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.